|
| 37775264 | Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiency. | J Med Genet | 2024 |
| 36250317 | Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France. | Int J Cancer | 2023 |
| 37549532 | Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial. | Eur J Cancer | 2023 |
| 37932266 | Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma. | Nat Commun | 2023 |
| 37379367 | Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma. | Sci Transl Med | 2023 |
| 37169337 | Pediatric Tumors and Developmental Anomalies: A French Nationwide Cohort Study. | J Pediatr | 2023 |
| 37357529 | Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib. | Br J Haematol | 2023 |
| 36858678 | Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma. | Lancet Haematol | 2023 |
| 36586540 | Constitutional Microsatellite Instability, Genotype, and Phenotype Correlations in Constitutional Mismatch Repair Deficiency. | Gastroenterology | 2023 |
| 36907641 | Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents. | Best Pract Res Clin Haematol | 2023 |
| 36411031 | High yield of surveillance in patients diagnosed with constitutional mismatch repair deficiency. | J Med Genet | 2023 |
| 34506008 | Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies. | Hepatol Int | 2022 |
| 35586965 | Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement. | Haematologica | 2022 |
| 35768194 | Cancer risk and tumour spectrum in 172 patients with a germline <i>SUFU</i> pathogenic variation: a collaborative study of the SIOPE Host Genome Working Group. | J Med Genet | 2022 |
| 35451547 | Prognostic impact of pulmonary nodules diagnosed at initial presentation in patients with osteosarcoma. | Pediatr Blood Cancer | 2022 |
| 33622763 | Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group. | J Med Genet | 2022 |
| 35078815 | Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis. | Cancer Res | 2022 |
| 34657149 | Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. | Blood | 2022 |
| 32393843 | Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents. | Leukemia | 2021 |
| 33687135 | Should treatment of ALK-positive anaplastic large cell lymphoma be stratified according to minimal residual disease? | Pediatr Blood Cancer | 2021 |
| 33484663 | Predisposition to cancer in children and adolescents. | Lancet Child Adolesc Health | 2021 |
| 33893148 | Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer. | Cancer Discov | 2021 |
| 33918346 | Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials? | Cancers (Basel) | 2021 |
| 33860896 | Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG). | Fam Cancer | 2021 |
| 33498676 | Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment? | Cancers (Basel) | 2021 |
| 34409296 | Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma. | Neurooncol Adv | 2021 |
| 34780708 | ALK inhibitors for ALK-altered paediatric malignancies. | Lancet Oncol | 2021 |
| 34174161 | Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. | Pediatr Blood Cancer | 2021 |
| 34335473 | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report. | Front Endocrinol (Lausanne) | 2021 |
| 33246076 | Minimal Residual Disease Monitoring Using a 3'ALK Universal Probe Assay in ALK-Positive Anaplastic Large-Cell Lymphoma: ddPCR, an Attractive Alternative Method to Real-Time Quantitative PCR. | J Mol Diagn | 2021 |
| 32648260 | Neuro-meningeal relapse in anaplastic large-cell lymphoma: incidence, risk factors and prognosis - a report from the European intergroup for childhood non-Hodgkin lymphoma. | Br J Haematol | 2021 |
| 31504825 | Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas. | Neuro Oncol | 2020 |
| 31702419 | Methotrexate-Etoposide-Ifosfamide Compared with Doxorubicin-Cisplatin-Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18-25 Years. | J Adolesc Young Adult Oncol | 2020 |
| 31838406 | A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma. | Eur J Cancer | 2020 |
| 31738008 | Exploring heterogeneity of adrenal cortical tumors in children: The French pediatric rare tumor group (Fracture) experience. | Pediatr Blood Cancer | 2020 |
| 32637605 | XAF1 as a modifier of p53 function and cancer susceptibility. | Sci Adv | 2020 |
| 32658383 | Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience. | Pediatr Blood Cancer | 2020 |
| 32573700 | IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma. | Blood | 2020 |
| 32730187 | Stem Cell Transplantation and Vinblastine Monotherapy for Relapsed Pediatric Anaplastic Large Cell Lymphoma: Results of the International, Prospective ALCL-Relapse Trial. | J Clin Oncol | 2020 |
| 32987765 | Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 Trial. | Cancers (Basel) | 2020 |
| 32618436 | Tumor rupture in hepatoblastoma: A high risk factor? | Pediatr Blood Cancer | 2020 |
| 32432211 | Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE). | J Endocr Soc | 2020 |
| 32296180 | Germline Elongator mutations in Sonic Hedgehog medulloblastoma. | Nature | 2020 |
| 32452165 | Rare non-Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma. | Pediatr Blood Cancer | 2020 |
| 31246277 | Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study. | Int J Cancer | 2020 |
| 31609649 | Germline <i>GPR161</i> Mutations Predispose to Pediatric Medulloblastoma. | J Clin Oncol | 2020 |
| 30528797 | Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report. | Eur J Cancer | 2019 |
| 31827960 | Difficulties of Management of Multiple Synchronous Bone Tumors in Li-Fraumeni Syndrome. | Case Rep Orthop | 2019 |
| 32642735 | NF1-like optic pathway gliomas in children: clinical and molecular characterization of this specific presentation. | Neurooncol Adv | 2019 |
| 32642664 | Constitutional mismatch repair deficiency-associated brain tumors: report from the European C4CMMRD consortium. | Neurooncol Adv | 2019 |